Edgewise Therapeutics Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline
Go back to Edgewise Therapeutics Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline| (NASDAQ: EWTX) | Delayed: 36.50 -0.31 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.81 | 52 Week High | $ | |||
| Open | $37.51 | 52 Week Low | $ | |||
| Day High | $37.51 | P/E | N/A | |||
| Day Low | $35.96 | EPS | $ | |||
| Volume | 1,158,465 | |||||
